SAGE and antibody array analysis of melanoma-infiltrated lymph nodes: Identification of Ubc9 as an important molecule in advanced-stage melanomas

Oncogene

Volumn 26, Issue 29, 2007, Pages 4216-4225

  Moschos, S J ^a   Smith, A P ^a   Mandic, M ^a   Athanassiou, C ^b   Watson Hurst, K ^a   Jukic, D M ^a   Edington, H D ^c   Kirkwood, J M ^a   Becker, D ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b Automated Cell Inc   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Apoptosis; Chemotherapy; Melanoma; Molecular profiling; Ubc9

Indexed keywords

CISPLATIN; COMPLEMENTARY DNA; DNA; PACLITAXEL; PROTEIN UBC9; SMALL INTERFERING RNA; TEMOZOLOMIDE;

ADVANCED CANCER; APOPTOSIS; ARTICLE; BIOINFORMATICS; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; CRYOPRESERVATION; DNA CONTENT; DNA SEQUENCE; DRUG CYTOTOXICITY; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LYMPH NODE; LYMPH NODE METASTASIS; MELANOMA; MELANOMA CELL; NEVUS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SERIAL ANALYSIS OF GENE EXPRESSION;

ANTIBODIES, NEOPLASM; ANTIGENS, NEOPLASM; APOPTOSIS; DRUG RESISTANCE, NEOPLASM; HUMANS; LYMPH NODES; MELANOMA; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PEPTIDE LIBRARY; PROTEIN ARRAY ANALYSIS; TUMOR CELLS, CULTURED; UBIQUITIN-CONJUGATING ENZYMES;

EID: 34250807853     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1210216     Document Type: Article

References (39)

1. Balch CM, Buzaid AC, Atkins MB, Cascinelli N, Coit DG, Fleming ID et al. (2000). A New American Joint Committee on Cancer staging system for cutaneous melanoma. Cancer 88: 1484-1491.
2. Balch CM, Soong SJ, Atkins MB, Buzaid AC, Cascinelli N, Coit DG et al. (2004). An evidence-based staging system for cutaneous melanoma. CA Cancer J Clin 54: 131-149.
3. Becker D, Meier CB, Herlyn M. (1989). Proliferation of human malignant melanomas is inhibited by antisense oligodeoxynucleotides targeted against basic fibroblast growth factor. EMBO J 8: 3685-3691.
4. Bolstad BM, Irizarry RA, Astrand M, Speed TP. (2003). A comparison of normalization methods for high-density oligonucleotide array data based on bias and variance. Bioinformatics 19: 185-193.
5. Edwards D. (2003). Non-linear normalization and background correction in one-channel cDNA microarray studies. Bioinformatics 19: 825-833.
6. Hayashi T, Seki M, Maeda D, Wang W, Kawabe Y, Seki T et al. (2002). Ubc9 is essential for viability of higher eukaryotic cells. Exp Cell Res 280: 212-221.
7. Herlyn M. (2006). Molecular targets in melanoma: strategies and challenges for diagnosis and therapy. Int J Cancer 118: 523-526.
8. Herlyn M, Rodeck U, Mancianti M, Cardillo FM, Lang A, Ross AH et al. (1987). Expression of melanoma-associated antigens in rapidly dividing human melanocytes in culture. Cancer Res 47: 3057-3061.
9. Hoege C, Pfander B, Moldovan GL, Pyrowolakis G, Jentsch S. (2002). RAD6-dependent DNA repair is linked to modification of PCNA by ubiquitin and SUMO. Nature 419: 135-141.
10. Johnson ES, Blobel G. (1997). Ubc9p is the conjugating enzyme for the ubiquitin-like protein Smt3p. J Biol Chem 272: 26799-26802.
11. Kovalenko OV, Plug AW, Haaf T, Gonda DK, Ashley T, Ward DC et al. (1996). Mammalian ubiquitin-conjugating enzyme Ubc9 interacts with Rad51 recombination protein and localizes in synaptonemal complexes. Proc Natl Acad Sci USA 93: 2958-2963.
12. Lin X, Liang M, Liang YY, Brunicardi FC, Feng XH. (2003). SUMO-1/Ubc9 promotes nuclear accumulation and metabolic stability of tumor suppressor Smad4. J Biol Chem 278: 31043-31048.
13. Lin JY, Ohshima T, Shimotohno K. (2004). Association of Ubc9, an E2 ligase for SUMO conjugation, with p53 is regulated by phosphorylation of p53. FEBS Lett 573: 15-18.
14. McDonald SL, Edington HD, Kirkwood JM, Becker D. (2004). Expression analysis of genes identified by molecular profiling of VGP melanomas and MGP melanoma-positive lymph nodes. Cancer Biol Ther 3: 121-123.
15. Mo YY, Yu Y, Ee PL, Beck WT. (2004). Overexpression of a dominant-negative mutant Ubc9 is associated with increased sensitivity to anticancer drugs. Cancer Res 64: 2793-2798.
16. Mo YY, Yu Y, Theodosiou E, Rachel Ee PL, Beck WT. (2005). A role for Ubc9 in tumorigenesis. Oncogene 24: 2677-2683.
17. Nacerddine K, Lehembre F, Bhaumik M, Artus J, Cohen-Tannoudji M, Babinet C et al. (2005). The SUMO pathway is essential for nuclear integrity and chromosome segregation in mice. Dev Cell 9: 769-779.
18. Perlis C, Herlyn M. (2004). Recent advances in melanoma biology. Oncologist 9: 182-187.
19. Premont RT, Claing A, Vitale N, Freeman JL, Pitcher JA, Patton WA et al. (1998). β2-adrenergic receptor regulation by GIT1, a G protein-coupled receptor kinase-associated ADP ribosylation factor GTPase-activating protein. Proc Natl Acad Sci USA 95: 14082-14087.
20. Rizos H, Woodruff S, Kefford RF. (2005). p14ARF interacts with the SUMO-conjugating enzyme Ubc9 and promotes the sumoylation of its binding partners. Cell Cycle 4: 597-603.
21. Rodriguez MS, Desterro JM, Lain S, Midgley CA, Lane DP, Hay RT. (1999). SUMO-1 modification activates the transcriptional response of p53. EMBO J 18: 6455-6461.
22. Saha S, Sparks AB, Rago C, Akmaev V, Wang CJ, Vogelstein B et al. (2002). Using the transcriptome to annotate the genome. Nat Biotechnol 20: 508-512.
23. Seufert W, Futcher B, Jentsch S. (1995). Role of a ubiquitin-conjugating enzyme in degradation of S- and M-phase cyclins. Nature 373: 78-81.
24. Smith AP, Hoek K, Becker D. (2005). Whole-genome expression profiling of the melanoma progression pathway reveals marked molecular differences between nevi/melanoma in situ and advanced-stage melanomas. Cancer Biol Ther 4: 1018-1029.
25. Smith AP, Weeraratna AT, Spears JR, Meltzer PS, Becker D. (2004). SAGE identification and fluorescence imaging analysis of genes and transcripts in melanomas and precursor lesions. Cancer Biol Ther 3: 104-109.
26. Tago K, Chiocca S, Sherr CJ. (2005). Sumoylation induced by the Arf tumor suppressor: a p53-independent function. Proc Natl Acad Sci USA 102: 7689-7694.
27. Tashiro K, Pando MP, Kanegae Y, Wamsley PM, Inoue S, Verma IM. (1997). Direct involvement of the ubiquitin-conjugating enzyme Ubc9/Hus5in the degradation of IkappaB alpha. Proc Natl Acad Sci USA 94: 7862-7867.
28. Tsao H, Atkins MB, Sober AJ. (2004). Management of cutaneous melanoma. N Engl J Med 351: 998-1012.
29. Ungureanu D, Vanhatupa S, Kotaja N, Yang J, Aittomaki S, Janne OA et al. (2003). PIAS proteins promote SUMO-1 conjugation to STAT1. Blood 102: 3311-3313.
30. Valesky M, Spang AJ, Fisher GW, Farkas DL, Becker D. (2002). Noninvasive dynamic fluorescence imaging of human melanomas reveals that targeted inhibition of bFGF or FGFR-1 in melanoma cells blocks tumor growth by apoptosis. Mol Med 8: 103-112.
31. Velculescu VE, Zhang L, Vogelstein B, Kinzler KW. (1995). Serial analysis of gene expression. Science 270: 484-487.
32. Wang Y, Becker D. (1997). Antisense targeting of basic fibroblast growth factor and fibroblast growth factor receptor-1 in human melanomas blocks intratumoral angiogenesis and tumor growth. Nat Med 3: 887-893.
33. Wang E, Panelli MC, Zavaglia K, Mandruzzato S, Hu N, Taylor PR et al. (2004). Melanoma-restricted genes. J Transl Med 15: 34.
34. Wang ZY, Qiu QQ, Seufert W, Taguchi T, Testa JR, Whitmore SA et al. (1996a). Molecular cloning of the cDNA and chromosome localization of the gene for human ubiquitin-conjugating enzyme 9. J Biol Chem 271: 24811-24816.
35. Wang Y, Rao U, Mascari R, Richards TJ, Panson AJ, Edington HD et al. (1996b). Molecular analysis of melanoma precursor lesions. Cell Growth Differ 7: 1733-1740.
36. Watanabe TK, Fujiwara T, Kawai A, Shimizu F, Takami S, Hirano H et al. (1996). Cloning, expression, and mapping of UBE2I, a novel gene encoding a human homologue of yeast ubiquitin-conjugating enzymes, which are critical for regulating the cell cycle. Cytogenet Cell Genet 72: 86-89.
37. Weeraratna AT, Becker D, Carr KM, Duray PH, Rosenblatt KP, Yang S et al. (2004). Generation and analysis of melanoma SAGE libraries: SAGE advice on the melanoma transcriptome. Oncogene 23: 2264-2274.
38. Xu W, Gong L, Haddad MM, Bischof O, Campisi J, Yeh ET et al. (2000). Regulation of microphthalmia-associated transcription factor MITF protein levels by association with the ubiquitin-conjugating enzyme hUBC9. Exp Cell Res 255: 135-143.
39. Yasugi T, Howley PM. (1996). Identification of the structural and functional human homolog of the yeast ubiquitin conjugating enzyme UBC9. Nucleic Acids Res 24: 2005-2010.